glp-1 drugs in development Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Current Insights, Advantages and Challenges

Look ARG, Gregg EW, Jakicic JM, et al

An overview of similarities and differences in metabolic actions and effects of central nervous system between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium glucose co-transporter-2 inhibitors (SGLT-2is) Diabetes, Metab

For identifying a rare side effect, RWE trials like the ones we analyzed are well established [27]

His team looked at data on almost 150,000 adults from a national database of patients with both diabetes and obesity

American College of Gastroenterology

Theres also research on psyllium fiber and feeling full and a highly viscous non-starch polysaccharide complex called PGX that increases [self-reported] feelings of satiety. But lets get real, he says